Surgery timing after chemoradiation for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at whether having surgery at the right time after chemoradiation improves outcomes for people with esophageal cancer. You might qualify if you have had (or are planning) chemoradiation and then are going to have surgery to remove the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have confirmed esophageal cancer (squamous cell or adenocarcinoma), or cancer where the esophagus meets the stomach.
- You had neoadjuvant chemoradiation (chemotherapy plus radiation) using the CROSS approach, then are planned for surgery or recently had it.
- Your baseline PET-CT scan shows the tumor lights up with FDG (it is FDG-avid).
- Your first treatment was not endoscopic resection (not removal through the scope).
- You are not being treated with definitive chemoradiation only (without surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding radiation to chemotherapy before surgery works better for people with operable (resectable) squamous cell esophageal cancer. It aims to improve outcomes by comparing two different treatment plans before the operation.
This study looks at whether giving radiation after surgery (after chemo and radiation before surgery) can improve outcomes for people with squamous cell esophagus cancer in the chest. You may be considered if you are well enough for treatment and your cancer has not spread.
This Phase 3 trial looks at the best next step after surgery for thoracic esophageal squamous cell cancer that has spread to nearby lymph nodes. It compares adding chemotherapy, adding chemoradiation (chemotherapy plus radiation), or not adding additional treatment right away, to see which approach works best and is safest.
This study compares two ways to treat a type of esophagus cancer: surgical removal (esophagectomy) versus chemoradiation (chemo plus radiation). It is for people with early-stage findings where scans suggest no lymph node spread.
This trial tests whether giving chemotherapy combined with immunotherapy before surgery works better than the standard chemoradiation for esophageal cancer that can be removed. It may help reduce tumor size and improve outcomes.
This trial tests a treatment plan that combines chemotherapy and immunotherapy before surgery, followed by radiation and immunotherapy after surgery for people with esophageal squamous cell cancer. It aims to see if this approach helps prevent the cancer from coming back.
Hear when a new Cancer of Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.